Institutional investors purchased a net $1.0 million shares of INO during the quarter ended September 2015, and now own 34.41% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 431.8 Thousand shares of Inovio Pharmaceuticals In...